Molekulaardiagnostika seadmed

This compliance document mandates that bidders submit a non-conditional offer confirming full adherence to all tender terms, provide pricing strictly in the prescribed Forms 2 & 3, prove equivalence for any referenced standards/brands, and—if bidding as a consortium—attach a joint-bid authorization, while forbidding the marking of price or numeric performance data as business secrets.

Viljandi Hospital is buying—only as a single, non-splittable lot—CE-marked Seegene-validated real-time PCR instruments and nucleic-acid extraction equipment that must be proven compatible with eight specified Seegene reagent kits; mandatory bid documents include a detailed parts list, 6-year maintenance cost schedule, 72- or 84-month service commitment, and precise page-numbered technical documentation, so only suppliers that already distribute Seegene-approved, CE-IVD systems and can price long-term service should bid.

This participation form merely requires bidders to confirm—without any technical or financial details—that they will supply, install and commission Seegene-compatible real-time PCR and nucleic-acid extraction devices as a single, sanctions-free turnkey package; no specific qualifications, experience or evaluation criteria are stated, so any firm able to source and integrate the specified equipment can consider bidding.

This cost-schedule form (Vorm 3) requires bidders to price one mandatory nucleic-acid extraction device plus a 7-year consumables package (40 k extractions, 12–60 k PCR plates/tubes) in euros excluding VAT; no technical or qualification criteria are shown, so any supplier able to meet the volumes and quote the lowest compliant lifecycle cost should consider bidding.

Viljandi Hospital is buying, in one non-divisible lot, real-time PCR instruments compatible with Seegene Inc reagents plus a nucleic-acid extraction device with all consumables, maintenance and repair; the award is 100 % price-based (lowest tax-excluded total wins) and bidders must simply submit a compliant offer that meets the technical/functional integration requirement.

Viljandi Hospital is buying, in a single non-divisible lot, Seegene-compatible real-time PCR instruments plus nucleic-acid extraction equipment complete with reagents, accessories and full-service maintenance—bidders must therefore prove they can supply this specific integrated workflow (technical compatibility is mandatory) and meet the standard ESPD qualification checks (no special financial or experience thresholds stated).

This open procurement by SA Viljandi Haigla seeks a single-lot supply of real-time PCR devices compatible with Seegene Inc reagents and a nucleic-acid extraction unit, all with consumables, service and repair; mandatory compliance with technical/functional integration is required, but specific qualifications, delivery terms and award criteria are not stated in the released excerpt.

Viljandi Hospital is buying as a single lot (no partial bids) Seegene-compatible real-time PCR instruments plus nucleic-acid extraction devices, each with full reagents, accessories and 5-year service; bidders must therefore supply and integrate both systems, provide Estonian-language support and warranty, and show prior Seegene compatibility experience—mandatory requirements, so only vendors that can deliver the complete validated workflow should bid.

This verification plan mandates that suppliers of real-time PCR and nucleic-acid extraction equipment must prove—within 45 days of installation and user training—full technical compatibility with eight specified Seegene Allplex reagent kits (respiratory, GI, HPV, STI panels) through prospective on-site verification, making prior Seegene experience and documented integration capability essential for any bidder.

This document is merely the blank “Form 1 – Joint-bid Power of Attorney” for the Viljandi Hospital Foundation tender “Molekulaardiagnostica equipment”; it contains no technical requirements, qualification criteria or evaluation rules—only spaces for lead and member bidders to fill in their names, reg. codes, addresses and e-mails when submitting a joint offer.